Xvie
also XVIE, Xvie XO
- Phase 1 injection · amniotic-fluid extracellular vesicles · Xtressé · trial NCT07482423 · developer page · sponsor targets Dec 2026 for phase 1/2 start (registry estimate) (said Aug 2026)
Amniotic-fluid extracellular-vesicle concentrate by Xtressé: a topical form used in clinics, and an injectable entering phase 1/2
Xvie is a product from Xtressé (Restore Biologics Holdings, Irvine, California, USA). It is made from donated human amniotic fluid with the cells removed, which leaves growth factors, extracellular vesicles (tiny particles released by cells, the family exosomes belong to) and hyaluronic acid. Two forms exist. Xvie XO Concentrate is applied to the scalp with in-office microneedling by licensed providers and is sold now; a 15-woman pilot study (NCT07221773) is under way. For an injectable form, the FDA accepted the company's Investigational New Drug application in March 2026, which lets human trials begin: a 30-person, placebo-controlled phase 1/2 trial (NCT07482423) with scalp injections on day 0 and day 90 and safety as the primary endpoint is planned to start in December 2026. No peer-reviewed efficacy data has been published; the claims so far are the company's own.
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research
— no indexed studies mention Xvie in a hair context yet
All on OpenAlex →Posts
— no r/tressless threads found for Xvie yet
View more on Reddit →